Stephanie Morley

Stephanie Morley is a declared insider of Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.), with filings sourced from SEDI. In total, 3 filings cover trades dated 12 April 2021.

Every open-market trade on record is a sale: 1 sale worth €622k. Besides market trades, the filings include 2 option exercises.

Most recently, on 15 April 2021, the filings show an open-market sale worth €622k in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). Filings reach the SEDI feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.